-
公开(公告)号：KR1020110028741A
公开(公告)日：2011-03-22
申请号：KR1020090086317
申请日：2009-09-14
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition for improving exercise endurance capacity and recovery capability is provided to form a health food with the composition containing chito-oligosaccharide. CONSTITUTION: A composition for improving exercise endurance capacity and recovery capability contains chito-oligosaccharide as an active component. The chito-oligosaccharide increases the utilization coefficient of internal fat acid of a user and reduces the concentration of lactic acid in blood. The chito-oligosaccharide additionally increases the storage content of glycogen of the user.
Abstract translation: 目的：提供一种用于提高运动耐力和恢复能力的组合物，以形成含有低聚半乳糖的组合物的保健食品。 构成：用于提高运动耐力和恢复能力的组合物含有作为活性成分的低聚半乳糖。 氯低聚糖增加了使用者的内部脂肪酸的利用系数，降低了血液中乳酸的浓度。 氯低聚糖另外增加了使用者糖原的储存量。
-
公开(公告)号：KR1020100134381A
公开(公告)日：2010-12-23
申请号：KR1020090052982
申请日：2009-06-15
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition for promoting the alcoholysis inside a human body is provided to use a post-heating fermented tea extract as an active ingredient for reducing hangover. CONSTITUTION: A composition for promoting the alcoholysis contains a post-heating fermented tea extract using non-pathogenic microorganisms as an active ingredient. The non-pathogenic microorganisms are selected from the group consisting of yeast, lactobacillus, saccharomyces genus, bacillus genus, and aspergillus genus. The composition promotes the activity of alcohol dehydrogenase and acetaldehyde dehydrogenase.
Abstract translation: 目的：提供一种用于促进人体内醇解的组合物，使用后加热发酵茶提取物作为减少宿醉的活性成分。 构成：用于促进醇解的组合物包含使用非致病微生物作为活性成分的后加热发酵茶提取物。 非病原微生物选自酵母，乳杆菌属，酵母属，芽孢杆菌属和曲霉属。 该组合物促进醇脱氢酶和乙醛脱氢酶的活性。
-
公开(公告)号：KR1020100127728A
公开(公告)日：2010-12-06
申请号：KR1020100049181
申请日：2010-05-26
Applicant: (주)아모레퍼시픽
CPC classification number: A61K36/48 , A23L2/52 , A23L33/105 , A61K2236/333 , A23V2200/30
Abstract: PURPOSE: A composition containing soybean extract isolated with low alcohol is provided to improve blood circulation and to treat obesity, diabetes, and hyperlipidemia. CONSTITUTION: A composition for improving blood circulation contains soybean extract isolating with 1-7% of C1-5 alcohol or fraction. The C1-5 alcohol is methanol, ethanol, isopropylalcohol, n-propylalcohol, n-butanol or isobutanol. The soybean extract or fraction contains adenosine. The fraction is an ethylacetate or butanol fraction. The composition suppresses thrombosis or cholesterol generation.
Abstract translation: 目的：提供含有用低分子量分离的大豆提取物的组合物，以改善血液循环和治疗肥胖症，糖尿病和高脂血症。 构成：用于改善血液循环的组合物含有用1-7％的C1-5醇或级分分离的大豆提取物。 C 1-5醇是甲醇，乙醇，异丙醇，正丙醇，正丁醇或异丁醇。 大豆提取物或级分含有腺苷。 馏分是乙酸乙酯或丁醇馏分。 该组合物抑制血栓形成或胆固醇的产生。
-
公开(公告)号：KR1020100127420A
公开(公告)日：2010-12-06
申请号：KR1020090045858
申请日：2009-05-26
Applicant: (주)아모레퍼시픽
IPC: A61K36/79 , A61K36/896 , A61K36/258
CPC classification number: A61K36/79 , A61K36/258 , A61K36/896 , A61K2300/00
Abstract: PURPOSE: A ginseng complex composition which enhances the bioavailability of saponin is provided to improve the physiological activity of ginseng saponin. CONSTITUTION: A ginseng complex composition for enhancing the bioavailability of saponiin contains Schisandra chinensis extract or Liriope platyphylla extract and ginseng extract containing saponin. The ginseng extract is ginseng fruit extract. The saponin is ginsenoside Re. A composition for enhancing the bioavailability of saponin contains Schisandra chinensis extract or Liriope platyphylla extract as an active ingredient.
Abstract translation: 目的：提高人参皂苷生理活性，提高皂角苷的生物利用度。 构成：提高saponiin生物利用度的人参复合物组合物含有五味子提取物或Liriope platyphylla提取物和含有皂苷的人参提取物。 人参提取物是人参水果提取物。 皂苷是人参皂甙Re。 用于提高皂角苷生物利用度的组合物含有五味子提取物或Liriope platyphylla提取物作为活性成分。
-
75.发明授权ＣＰＴ-１ 유전자의 발현을 특이적으로 전사 단계에서조절하는 화학물질의 스크리닝 방법 및 그 방법으로검색된 제니스테인을 유효 성분으로 포함하는 ＣＰＴ-１발현 촉진제 有权用于表达CPT-1基因的控制剂的筛选方法，以及通过该方法筛选的包含染料木素的CPT-1表达增强子
公开(公告)号：KR100994632B1
公开(公告)日：2010-11-15
申请号：KR1020030095226
申请日：2003-12-23
Applicant: (주)아모레퍼시픽
IPC: C12N15/85
Abstract: 본 발명은, CPT-1 프로모터와 루시퍼라제를 포함하는 재조합 플라스미드; 상기 플라스미드로 형질전환된 Huh7 세포주 (수탁번호: KCLRF-BP-00090); 상기 세포를 이용하는 것을 특징으로 하는, CPT-1 유전자의 발현을 특이적으로 전사 단계에서 조절하는 화학물질의 스크리닝 방법에 관한 것이며,
또한 본 발명은, 상기의 스크리닝 방법으로 검색된 제니스테인을 유효 성분으로 포함하는 CPT-1 발현 촉진제; 그리고 상기의 스크리닝 방법으로 검색된 제니스테인을 유효 성분으로 포함하는 지방산의 베타 산화 촉진제에 관한 것이다.
제니스테인, CPT-1 유전자, 지방산의 베타 산화촉진제.-
Patent Agency Ranking
公开(公告)号：KR100989834B1
公开(公告)日：2010-10-29
申请号：KR1020060119449
申请日：2006-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K31/722 , C08B37/00
CPC classification number: A61K31/722
Abstract: 본 발명은 키토올리고당을 유효성분으로 함유하는 피로 개선용 조성물 및 AMPK 활성 촉진용 조성물에 관한 것으로, 보다 상세하게는 키토올리고당을 함유하여 AMPK 및 지방대사 관련 효소에 영향을 줌으로써 간세포에서의 에너지 대사를 촉진시키는 조성물에 관한 것이다.
키토올리고당, AMPK, 활성, 촉진, 간세포, 에너지대사-
公开(公告)号：KR100962991B1
公开(公告)日：2010-06-10
申请号：KR1020080010405
申请日：2008-01-31
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 초고압기술을 이용한 녹차의 제조방법에 관한 것으로서, 보다 상세하게는 녹차 잎을 60℃ 이하에서 200Mpa 이상의 압력으로 1분 이상 초고압 처리함으로써 카테킨류, 아미노산류 및 당류 등의 유효성분을 증대시키는 녹차의 제조방법에 관한 것이다.
녹차, 초고압, 카테킨류, 아미노산류, 당류-
公开(公告)号：KR1020100048643A
公开(公告)日：2010-05-11
申请号：KR1020080107902
申请日：2008-10-31
Applicant: (주)아모레퍼시픽 , 연세대학교 산학협력단
IPC: A61K8/97 , A61K36/906 , A61Q19/08
Abstract: PURPOSE: A composition containing Curcuma xanthorrhiza extract for anti-aging is provided to prevent side effects to the human body and to treat wrinkle and dryness. CONSTITUTION: A composition for anti-aging contains Curcuma xanthorrhiza extract as an active ingredient. The Curcuma xanthorrhiza extract is isolated using ethanol. A pharmaceutical composition contains The Curcuma xanthorrhiza as an active ingredient. The Curcuma xanthorrhiza is contained in 10-80 weight% of pharmaceutical composition as an active ingredient.
Abstract translation: 目的：提供含有姜黄黄疸提取物抗衰老的组合物，以防止对人体的副作用并治疗皱纹和干燥。 构成：抗衰老组合物含有黄姜黄素提取物作为活性成分。 使用乙醇分离姜黄提取物。 药物组合物含有黄姜黄酮作为活性成分。 黄姜黄酮含量为10-80重量％的药物组合物作为活性成分。
-
公开(公告)号：KR1020090084315A
公开(公告)日：2009-08-05
申请号：KR1020080010405
申请日：2008-01-31
Applicant: (주)아모레퍼시픽
Abstract: A method for processing green tea using ultra-high pressure technology is provided to produce green tea which is resistant contamination by microorganism or various germs and preserves deodorizing degree or flavor for a long time. Green tea leaves are processed at the temperature of 20~45‹C and the pressure of 200~600Mpa for 1~15 minutes. The distilled rate of amino acid and catechin is low in case of pressure less than 200Mpa, and green tea leaves are lumped in case of pressure over 600Mpa. In case that the pressure is 600Mpa or greater, the temperature is controlled lower than 60‹C in order to prevent oxidation of active substances of green tea leaves such as polyphenol.
Abstract translation: 提供一种使用超高压技术处理绿茶的方法，用于生产绿茶，其耐受微生物或各种细菌污染并长期保存除臭度或风味。 绿茶叶在20〜45℃的温度和200〜600Mpa的压力下加工1〜15分钟。 压力小于200Mpa时，氨基酸和儿茶素的蒸馏率较低，如果压力超过600Mpa，则绿茶叶会凝结。 在压力为600Mpa以上的情况下，为了防止多酚等绿茶叶的活性物质的氧化，将温度控制在60℃以下。
-
公开(公告)号：KR1020090054723A
公开(公告)日：2009-06-01
申请号：KR1020070121551
申请日：2007-11-27
Applicant: (주)아모레퍼시픽
Abstract: A skin cosmetic composition for oral administration is provided to promote the expression of filaggrin and involucrin and prevent the damage of skin barrier caused by drying and UV ray. A skin cosmetic composition for oral administration comprises 10-100 weight% of curcumin as an active ingredient. The composition for oral administration is a composition for promoting skin moisturizing and expressions of filaggrin and involucrin. The composition is used in a form of beverage, pill, granule, tablet or capsule.
Abstract translation: 提供用于口服给药的皮肤化妆品组合物以促进丝聚蛋白和内皮蛋白的表达，并防止由干燥和紫外线引起的皮肤屏障损伤。 用于口服给药的皮肤化妆品组合物包含10-100重量％的作为活性成分的姜黄素。 用于口服给药的组合物是用于促进皮肤保湿和丝胶蛋白和内皮蛋白的表达的组合物。 该组合物以饮料，丸剂，颗粒剂，片剂或胶囊剂的形式使用。
-
-
-
-
-
-
-
-
-
Search Results
274
records
(took 0.031 seconds)
